August 05, 2017

Alexion Pharmaceuticals, Inc. (NASD:ALXN) Zacks Rank: 1-Strong Buy

$136.64 USD (As of 08/04/2017) Style : Value: Growth: Momentum: VGM:

Target Price $157.00 Price, Consensus & Surprise

52 Week High-Low $145.42 - $96.18
20 Day Average
1,754,815
Volume

Beta 1.41
Market Cap 30.50 B
Dividend / Div Yld $0.00 / 0.00%
Industry Medical - Biomed..

108 / 265 (Top

Industry Rank
41%)

Proj. EPS Growth (Q1) -4.24%

Proj. EPS Growth (F1) 26.09%
P/E (F1) 28.67

Last EPS Surprise 21.30%

Avg. Last 4 Surprises 12.26%

Next Report Date 10/26/2017

Earnings ESP 0.00%

Agreement Estimate Revisions (60 Days) Magnitude Consensus Estimate Trend (60 Days)

Q1 Q2 F1 F2 Q1 Q2 F1 F2
# of Analysts 1 1 8 1 Current 1.13 1.24 4.77 6.43

# of Revisions 1 1 7 1 7 Days Ago 1.13 1.24 4.79 6.43

# Up 0 1 7 1 30 Days Ago 1.16 1.15 4.55 5.49

# Down 1 0 0 0 60 Days Ago 1.16 1.15 4.54 5.49

Trend of
% Revision Agreement: 100% 100% 100% 100% Estimate
Revisions: -2.59% +7.83% +5.07% +17.12%

Industry Comparison Medical - Biomed.. | Position in Industry: 1 of 246 Industry Peers

ALXN X Industry S&P 500 ILMN VRTX QGEN

Hist. EPS Growth (3-5 yrs) 19.51% 19.51% 7.16% 25.50% NA 2.05%
Proj. Sales Growth (F1/F0) 14.28% 0.00% 5.19% 11.60% 29.76% 5.89%
Net Margin 15.31% -293.48% 9.92% 30.27% 12.05% 5.44%
Return on Equity 12.47% -58.53% 15.95% 19.69% 4.64% 11.04%
Debt/Capital 25.77% 0.00% 41.54% 31.51% 1.34% 35.58%
P/E (F1) 28.68 25.75 18.89 54.49 406.68 25.77
Price/Sales (P/S) 8.94 13.12 2.50 11.65 18.22 5.41
Price/Book (P/B) 3.44 3.44 3.22 10.67 20.80 2.92
Price/Cash Flow (P/CF) 22.75 22.38 13.54 42.39 1,100.09 14.86
YTD % Price Change 11.74% 2.43% 9.77% 55.00% 109.08% 11.25%

Description Medical > Drugs > Medical - Biomedical And Genetics

Alexion Pharmaceuticals develops pharmaceutical products for the treatment of heart disease, and inflammation, diseases of the immune
system and cancer in humans. The company's lead product candidates are genetically altered antibodies that target specific diseases
which arise when the human immune system induces undesired inflammation in the human body. These candidates are designed to
block components of the human immune system which cause undesired inflammation while allowing beneficial components of the
immune system to remain functional.

Learn More about Zacks Rank and Style Scores